This valuable newsletter provides pharmacists, physicians, and other health care professionals with comprehensive summaries of adverse drug reactions, drug interactions, and market withdrawals from over 100 key medical and research journals from around the world. CLIN-ALERT’s primary focus is drug-drug interactions, but it also explores food-drug interactions, medication errors and dietary supplements.
- The primary drug suspected, (including common trade names, dosages, and duration of therapy)
- The adverse drug reaction/interaction
- Relevant laboratory data
- Management of the reaction
- Any relevant pre-existing condition
- Potential legal repercussions
- Complete journal citation including reprint information.
CLIN-ALERT also features First Report—notice of the first documented report of an adverse clinical event.
This journal is a member of the Committee on Publication Ethics (COPE).
Clin-Alert presents summaries of adverse clinical pharmaceutical events. Its primary focus is adverse drug events and drug-drug interactions, but it also explores food-drug interactions, medication errors and dietary supplements
|Joyce A. Generali, RPh, MS, FASHP||Director, Drug Information Center|
|Colleen Culley, PharmD, RPh|
|Kate Farthing, PharmD, RPh||Pharmacy Clinical Coordinator, Legacy Salmon Creek Medical Center, Canada|
|Aryeh Hurwitz, MD|
|William N. Kelly, PharmD, RPh||Mercer University, Dept of Clinical and Administrative Sciences, Atlanta, GA, USA|
|Sondra May, Pharm.D.||University of Colorado Hospital, USA|
|Jacyntha Sterling, PharmD, RPh||Saint Francis Hospital, Tulsa, Oklahoma, USA|